Ph1b study of the PI3K inhibitor GDC-0032 in combination with fulvestrant in patients with hormone receptor-positive advanced breast cancer Meeting Abstract
| Authors: | Juric, D.; Saura, C.; Cervantes, A.; Kurkjian, C.; Patel, M. R.; Sachdev, J.; Mayer, I.; Krop, I. E.; Oliveira, M.; Sanabria, S.; Cheeti, S.; Lin, R. S.; Graham, R. A.; Wilson, T. R.; Parmar, H.; Hsu, J. Y.; Von Hoff, D. D.; Baselga, J. |
| Abstract Title: | Ph1b study of the PI3K inhibitor GDC-0032 in combination with fulvestrant in patients with hormone receptor-positive advanced breast cancer |
| Meeting Title: | 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 73 |
| Issue: | 24 Suppl. |
| Meeting Dates: | 2013 Dec 10-14 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2013-12-15 |
| Language: | English |
| ACCESSION: | WOS:000209496903052 |
| DOI: | 10.1158/0008-5472.sabcs13-pd1-3 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: PD1-3 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
